A LC–MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1

Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption

2004 • 1,697 citations

Bioanalytical method validation--a revisit with a decade of progress.

2000 • 1,554 citations

Ezetimibe

2005 • 436 citations

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

2004 • 419 citations

Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia

2003 • 395 citations

Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

2000 • 324 citations

Ezetimibe Effectively Reduces Plasma Plant Sterols in Patients With Sitosterolemia

2004 • 296 citations

Disposition of the Selective Cholesterol Absorption Inhibitor Ezetimibe in Healthy Male Subjects

2002 • 164 citations

IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF EZETIMIBE (ZETIA)

2004 • 138 citations

Pharmacodynamic and pharmaco-kinetic interaction between fenofibrate and ezetimibe*

2004 • 61 citations

Assessment of a multiple-dose drug interaction between ezetimibe, a novel selective cholesterol absorption inhibitor and gemfibrozil

2004 • 37 citations

Inhibition of SN-38 glucuronidation by ketoconazole

2005 • 9 citations